Overview

Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects

Status:
Terminated
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This pilot trial seeks to obtain preliminary data on the effects of eicosapentaenoic acid (EPA) (4g/d) on endothelial function measured via endopat2000 after 12 weeks of intervention among adults with elevated triglycerides and type 2 diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Brigham and Women's Hospital
Treatments:
Eicosapentaenoic acid ethyl ester